Ein kontroverser Start-Up Unternehmen, dass verspricht, "Jugend-Blut" zu verkaufen, öffnet seine erste Klinik in NYC

A controversial start-up company promising to sell "youth blood" is opening its first clinic in NYC

Well, if this isn't the closest thing to "True Blood" you've ever heard of...


The best hotel deals in New York!

According to a recent newspaper article, a California startup called Ambrosia Medical will open a flagship location in New York City where you can fill your veins with the blood of young people starting later this year.

Founded by Stanford graduate Jesse Karmazin, the company recently completed its first clinical trial to evaluate the benefits of blood transfusions from young people into older bodies. According to Karmazin, the hope is that the procedure will help fight aging by rejuvenating the body's internal organs.

Back in 2017, Ambrosia enrolled people in the first U.S. clinical trial to find out what happens when adult veins are filled with blood from teenagers. The results of that study - which consisted of transfusing patients with 1.5 liters of plasma from a donor between the ages of 16 and 25 over two days - have not yet been published, but Karmazin told Business Insider in an interview that the results were “really positive”.

Blood transfusions have apparently already been approved by the Food and Drug Administration and are used every day in normal and necessary medical procedures. Ambrosia's treatment approach was to continue to market itself as an "off-label" treatment.

And people are already crazy about it. Promises of eternal youth have always fascinated humanity and Ambrosia struck a chord with people. Since launching their website last week, over 100 people have been added to their newly created waiting list.

Researchers from across the country are opposing the procedure. For starters, the 150 patients who participated in the first study actually paid more than $8,000 to be a part of it, making it difficult to determine the legitimacy of the results. Additionally, Stanford University neuroscientist Tony Wyss-Coray, who led a 2014 study of young plasma in mice, was recently quoted as saying: "There's just no clinical evidence [that the treatment will be beneficial] and you're basically abusing that People's trust and public enthusiasm about it."

But for $8,000 you can also get a gym membership and take a trip to Whole Foods. Something proven to improve health and physical function.

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.